Fingolimod Versus Teiflunomide- Health Care Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Therapies In The United States
May 1, 2016, 00:00
10.1016/j.jval.2016.03.221
https://www.valueinhealthjournal.com/article/S1098-3015(16)00289-8/fulltext
Title :
Fingolimod Versus Teiflunomide- Health Care Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Therapies In The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00289-8&doi=10.1016/j.jval.2016.03.221
First page :
A69
Section Title :
Neurological Disorders - Health Care Use & Policy Studies
Open access? :
No
Section Order :
1571